Kringle Pharma Yönetim

Yönetim kriter kontrolleri 1/4

Kringle Pharma's CEO is Kiichi Adachi, appointed in Dec 2016, has a tenure of 7.92 years. directly owns 1.12% of the company’s shares, worth ¥62.47M. The average tenure of the management team and the board of directors is 1.9 years and 5.9 years respectively.

Anahtar bilgiler

Kiichi Adachi

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi7.9yrs
CEO sahipliği1.1%
Yönetim ortalama görev süresi1.9yrs
Yönetim Kurulu ortalama görev süresi5.9yrs

Son yönetim güncellemeleri

Recent updates

Here's Why We're Not Too Worried About Kringle Pharma's (TSE:4884) Cash Burn Situation

Jun 15
Here's Why We're Not Too Worried About Kringle Pharma's (TSE:4884) Cash Burn Situation

We Think Kringle Pharma (TSE:4884) Can Afford To Drive Business Growth

Mar 02
We Think Kringle Pharma (TSE:4884) Can Afford To Drive Business Growth

CEO

Kiichi Adachi (57 yo)

7.9yrs

Görev süresi

Kiichi Adachi, Ph D., has been President at Kringle Pharma, Inc since December 27, 2016. Kiichi Adachi serves as a Director of Kringle Pharma, Inc. since December 2005.Kiichi Adachi was Research Scientist...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Kiichi Adachi
President & Director7.9yrsVeri yok1.12%
¥ 62.5m
Tomoya Shimojo
Chief Financial Officer & Director of Accounting and Corporate Planningno dataVeri yokVeri yok
Kunio Matsumoto
Chief Scientific Officerno dataVeri yokVeri yok
Koichi Murakami
GM of Corporate Planning Management Department & Directorno dataVeri yokVeri yok
Daichika Hayata
GM of Pharmaceutical Development and Pharmaceutical Affairs Department & Director1.9yrsVeri yokVeri yok
Yoshiyuki Kayano
Director & GM of Quality Assurance Departmentless than a yearVeri yokVeri yok

1.9yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: 4884's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Kiichi Adachi
President & Director18.9yrsVeri yok1.12%
¥ 62.5m
Koichi Murakami
GM of Corporate Planning Management Department & Director2.9yrsVeri yokVeri yok
Daichika Hayata
GM of Pharmaceutical Development and Pharmaceutical Affairs Department & Director1.9yrsVeri yokVeri yok
Yoshiyuki Kayano
Director & GM of Quality Assurance Departmentless than a yearVeri yokVeri yok
Kohichiro Yoshino
Independent Outside Director5.9yrsVeri yokVeri yok
Akihiro Tomoyasu
Part Time Director7.9yrsVeri yokVeri yok
Kazuto Ninomiya
Audit & Supervisory Board Member5.9yrsVeri yokVeri yok
Masahiro Motokawa
Audit & Supervisory Board Member5.9yrsVeri yokVeri yok
Yosuke Yamaguchi
Audit & Supervisory Board Member5.9yrsVeri yokVeri yok
Masato Fukui
Independent Outside Director3.9yrsVeri yokVeri yok

5.9yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 4884's board of directors are considered experienced (5.9 years average tenure).